AZD-0284 is primarily investigated for its potential therapeutic applications in the field of oncology. It functions as a kinase inhibitor, targeting specific enzymes involved in the regulation of cancer cell growth and proliferation. By inhibiting these kinases, AZD-0284 aims to disrupt the signaling pathways that contribute to tumor development and progression. This makes it a promising candidate for the treatment of various cancers, particularly those driven by the dysregulation of kinase activity. Research is ongoing to evaluate its efficacy, safety, and potential use in combination with other cancer therapies to enhance treatment outcomes.